| Cover | Feb. 02, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Feb. 02, 2024 |
| Current Fiscal Year End Date | --04-30 |
| Entity File Number | 001-40483 |
| Entity Registrant Name | ALZAMEND NEURO, INC. |
| Entity Central Index Key | 0001677077 |
| Entity Tax Identification Number | 81-1822909 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 3480 Peachtree Road NE |
| Entity Address, Address Line Two | Second Floor |
| Entity Address, Address Line Three | Suite 103 |
| Entity Address, City or Town | Atlanta |
| Entity Address, State or Province | GA |
| Entity Address, Postal Zip Code | 30326 |
| City Area Code | (844) |
| Local Phone Number | 722-6333 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value |
| Trading Symbol | ALZN |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
